MyFinsight
Home
Blog
About
Comprehensive loss
-$738,391
(66.70%↑ Y/Y)
Net loss attributed
to abvc and...
-$736,934
(67.35%↑ Y/Y)
Foreign currency
translation adjustment
-$1,457
(-103.68%↓ Y/Y)
Net loss
attributable to...
-$73,547
(2.99%↑ Y/Y)
Net loss
-$810,481
(65.26%↑ Y/Y)
Loss before
provision income tax
-$810,481
(64.90%↑ Y/Y)
Loss from operations
-$779,526
(66.03%↑ Y/Y)
Total other expenses
-$30,955
(-117.64%↓ Y/Y)
Operating sublease income
$17,207
(43.39%↑ Y/Y)
Gain (loss) on
foreign exchange
$11,378
(-91.64%↓ Y/Y)
Other income
(expenses)
$6,866
(195.63%↑ Y/Y)
Interest income
$683
(-96.43%↓ Y/Y)
Total operating
expenses
$779,526
(-66.03%↓ Y/Y)
Interest expense
$42,323
(-67.30%↓ Y/Y)
Loss on investment in
equity securities
-$24,766
(44.86%↑ Y/Y)
Selling, general and
administrative expenses
$503,778
(-27.00%↓ Y/Y)
Stock-based compensation
$253,041
(-83.90%↓ Y/Y)
Research and development
expenses
$22,707
(-31.76%↓ Y/Y)
Back
Back
Income Statement
ABVC BIOPHARMA, INC. (ABVC)
ABVC BIOPHARMA, INC. (ABVC)
source: myfinsight.com